Method and means for preventing and inhibiting type III secretion in infections caused by gram-negative bacteria

Details for Australian Patent Application No. 2008227216 (hide)

Owner INNATE PHARMACEUTICALS AB

Inventors Elofsson, Mikael

Agent EF WELLINGTON & CO

Pub. Number AU-A-2008227216

PCT Pub. Number WO2008/115118

Priority 0701509-2 21.06.07 SE; 0700695-0 21.03.07 SE

Filing date 18 March 2008

Wipo publication date 25 September 2008

International Classifications

A61K 31/47 (2006.01) - Quinolines

A01N 43/00 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A01P 1/00 (2006.01) Disinfectants

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

1 October 2009 PCT application entered the National Phase

  PCT publication WO2008/115118 Priority application(s): WO2008/115118

26 November 2009 Alteration of Name

  The name of the applicant has been altered to Creative Antibiotics Sweden AB

5 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008227219-Phosphorus recovery

2008227194-Process for synthesis of clay particles